chr16-5073200-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_019109.5(ALG1):​c.334A>C​(p.Met112Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00233 in 1,614,118 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M112T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 36 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 38 hom. )

Consequence

ALG1
NM_019109.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.133

Publications

5 publications found
Variant links:
Genes affected
ALG1 (HGNC:18294): (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase) The enzyme encoded by this gene catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. This gene is mutated in congenital disorder of glycosylation type Ik. [provided by RefSeq, Dec 2008]
ALG1 Gene-Disease associations (from GenCC):
  • ALG1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029365122).
BP6
Variant 16-5073200-A-C is Benign according to our data. Variant chr16-5073200-A-C is described in ClinVar as Benign. ClinVar VariationId is 384254.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0116 (1773/152224) while in subpopulation AFR AF = 0.0401 (1667/41540). AF 95% confidence interval is 0.0385. There are 36 homozygotes in GnomAd4. There are 850 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 36 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG1NM_019109.5 linkc.334A>C p.Met112Leu missense_variant Exon 3 of 13 ENST00000262374.10 NP_061982.3 Q9BT22-1
ALG1NM_001438123.1 linkc.334A>C p.Met112Leu missense_variant Exon 3 of 12 NP_001425052.1
ALG1NM_001330504.2 linkc.1A>C p.Met1? initiator_codon_variant Exon 3 of 13 NP_001317433.1 Q9BT22-2
ALG1XR_007064892.1 linkn.341A>C non_coding_transcript_exon_variant Exon 3 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG1ENST00000262374.10 linkc.334A>C p.Met112Leu missense_variant Exon 3 of 13 1 NM_019109.5 ENSP00000262374.5 Q9BT22-1

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1763
AN:
152106
Hom.:
35
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0400
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00413
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00815
GnomAD2 exomes
AF:
0.00315
AC:
792
AN:
251490
AF XY:
0.00240
show subpopulations
Gnomad AFR exome
AF:
0.0405
Gnomad AMR exome
AF:
0.00272
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000237
Gnomad OTH exome
AF:
0.00195
GnomAD4 exome
AF:
0.00136
AC:
1986
AN:
1461894
Hom.:
38
Cov.:
32
AF XY:
0.00121
AC XY:
881
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0430
AC:
1439
AN:
33480
American (AMR)
AF:
0.00277
AC:
124
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5768
European-Non Finnish (NFE)
AF:
0.000174
AC:
193
AN:
1112012
Other (OTH)
AF:
0.00334
AC:
202
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
127
254
382
509
636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0116
AC:
1773
AN:
152224
Hom.:
36
Cov.:
33
AF XY:
0.0114
AC XY:
850
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0401
AC:
1667
AN:
41540
American (AMR)
AF:
0.00412
AC:
63
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68008
Other (OTH)
AF:
0.00806
AC:
17
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
90
181
271
362
452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00213
Hom.:
7
Bravo
AF:
0.0134
ESP6500AA
AF:
0.0385
AC:
169
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00395
AC:
480
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

ALG1-congenital disorder of glycosylation Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
5.4
DANN
Benign
0.71
DEOGEN2
Benign
0.043
.;T;T;T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.51
.;T;T;D;D
MetaRNN
Benign
0.0029
T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-1.2
.;N;.;.;.
PhyloP100
-0.13
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.59
.;N;.;.;N
REVEL
Benign
0.16
Sift
Benign
1.0
.;T;.;.;T
Sift4G
Benign
1.0
T;T;T;T;T
Polyphen
0.0
.;B;.;.;.
Vest4
0.19
MutPred
0.50
.;Loss of MoRF binding (P = 0.0852);Loss of MoRF binding (P = 0.0852);.;.;
MVP
0.52
MPC
0.038
ClinPred
0.0048
T
GERP RS
-2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.052
gMVP
0.46
Mutation Taster
=149/51
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113219939; hg19: chr16-5123201; API